Prostate Cancer Clinical Trial

Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

Summary

The purpose of this study is to evaluate the immune response induced by sipuleucel-T (Provenge®).

View Full Description

Full Description

Subjects will receive sipuleucel-T, and potentially other medications, as part of the clinical trial in which they are concurrently enrolled. For this study, cellular and humoral immune responses will be assessed. No additional study treatments will be conducted beyond what is required for the subject's concurrent clinical trial.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Subjects must be at least 18 years of age
Subjects with prostate cancer who are enrolled in a clinical trial of sipuleucel-T (including a Dendreon-sponsored clinical trial or registry, or an IIT)
Subjects have not yet undergone leukapheresis for their first dose of sipuleucel-T
Subjects must understand and sign an informed consent form prior to their first leukapheresis

Exclusion Criteria:

•None

Study is for people with:

Prostate Cancer

Estimated Enrollment:

139

Study ID:

NCT01727154

Recruitment Status:

Terminated

Sponsor:

Dendreon

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 39 Locations for this study

See Locations Near You

21st Century Oncology
Scottsdale Arizona, 85251, United States
Tower Urology / Tower Research Institute
Los Angeles California, 90048, United States
Prostate Oncology Specialists, Inc.
Marina Del Rey California, 90292, United States
The Urology Center of Colorado
Denver Colorado, 80211, United States
Howard University Cancer Center
Washington District of Columbia, 20060, United States
First Urology, PSC
Jeffersonville Indiana, 47130, United States
Cancer Center of Kansas
Wichita Kansas, 67214, United States
Tulane University
New Orleans Louisiana, 70112, United States
Highland Clinic
Shreveport Louisiana, 71106, United States
Chesapeake Urology Research Associates
Towson Maryland, 21204, United States
Tufts Medical Center
Boston Massachusetts, 02111, United States
Henry Ford Health System
Detroit Michigan, 48202, United States
Michigan Institute of Urology
Troy Michigan, 48084, United States
St. Louis Cancer Care, LLP
Bridgeton Missouri, 63044, United States
St. Louis Cancer Care, LLP
Saint Louis Missouri, 63127, United States
Southeast Nebraska Hematology & Oncology Consultants, P.C. d/b/a Southeast Nebraska Cancer Center
Lincoln Nebraska, 68510, United States
Comprehensive Cancer Centers of Nevada
Henderson Nevada, 89052, United States
Comprehensive Cancer Centers of Nevada
Las Vegas Nevada, 89169, United States
Delaware Valley Urology, LLC
Mount Laurel New Jersey, 08054, United States
Montefiore Medical Center
Bronx New York, 10461, United States
National Translational Research Group, Inc.
East Setauket New York, 11733, United States
Premier Medical Group of the Hudson Valley
Poughkeepsie New York, 12601, United States
Associated Medical Professionals of NY, PLLC
Syracuse New York, 13210, United States
Carolina Urology Partners
Gastonia North Carolina, 28054, United States
Raleigh Hematology Oncology Associates, D.B.A., Cancer Centers of North Carolina
Raleigh North Carolina, 27607, United States
TriState Urologic Services PSC Inc., dba The Urology Group
Cincinnati Ohio, 45212, United States
Urologic Specialists of Oklahoma
Tulsa Oklahoma, 74146, United States
Providence Health & Services
Portland Oregon, 97213, United States
Oregon Urology Institute
Springfield Oregon, 97477, United States
Northwest Cancer Specialists, PC
Tualatin Oregon, 97062, United States
Urologic Consultants of SE PA
Bala-Cynwyd Pennsylvania, 19004, United States
South Carolina Oncology Associates
Columbia South Carolina, 29210, United States
Carolina Urologic Research Center
Myrtle Beach South Carolina, 29572, United States
Urology Associates, P.C.
Nashville Tennessee, 37209, United States
Texas Oncology - Fort Worth
Fort Worth Texas, 76104, United States
Urology of Virginia, PLLC
Virginia Beach Virginia, 23462, United States
Seattle Cancer Care Alliance
Seattle Washington, 98109, United States
University of Washington Medical Centerl
Seattle Washington, 98195, United States
Northwest Cancer Specialists
Vancouver Washington, 98684, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

139

Study ID:

NCT01727154

Recruitment Status:

Terminated

Sponsor:


Dendreon

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider